Track the 이엔셀 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 이엔셀 has logged 33 insider filings. Market capitalisation: €79.5bn. The latest transaction was disclosed on 25 June 2026 (Other). Among the most active insiders: 장종욱. The full history is openly available.
33
Insider Decl.
0
Thresholds
·
15 ops.
Buy Volume
€1m
4 ops.
Sell Volume
22Σ signal
Buys ·€1m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,546 of 25,837 companies
7.4
score / 100
Value
11
Quality
4
FCF yld-17%
Earn yld-21%
EV/EBITDA·
ROE-42%
Gross mgn-46%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.